[AQST] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[AQST] Aquestive Therapeutics, Inc.
Announcement Date
01-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 36.82%
YoY- 13.87%
Quarter Report
AQST's Result
AQST's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 13,241 11,134 10,682 11,463 13,265 12,270 11,078 12.66%
PBT -5,508 8,068 -12,352 -12,536 -16,302 -13,220 -28,945 -67.01%
Tax 284 -11,238 5,797 5 3,540 3,482 19,020 -93.98%
NP -5,792 19,306 -18,149 -12,536 -19,842 -16,702 -28,945 -65.88%
Tax Rate - 139.29% - - - - - -
Total Cost 19,033 -8,172 28,831 23,999 33,107 28,972 40,023 -39.15%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -43.74 173.40 -169.90 -109.36 -149.58 -136.12 -261.28 -69.72%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.10 0.35 -0.33 -0.23 -0.44 -0.40 -0.72 -73.27%
EPS Diluted -0.10 0.26 -0.33 -0.23 -0.44 -0.40 -0.72 -73.27%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.